A few weeks ago, as we briefly covered news on Insys Therapeutics, we realized that the ripples of its scandal would be felt across the pond. And indeed, qordata finds many compliance professionals in the EU pharma industry voicing concerns about the possibility of something like this happening in their own markets. The fact that […]

There’s a reason business lingo has so much of what I would call ‘war words’: Starting with the all-famous “strategy”, to “target”, “guerilla tactics,” “mission,” “red ocean” and so on. The way I see it, the reason is that in war as in business, rivals compete ruthlessly for the same reward in a challenging and […]